AnaptysBio, Inc. (ANAB)

52.83 -2.08 (-3.79%) USD  |  NASDAQ  |  Mar 03, 16:00
55.10 +2.27 (+4.30%) After-Hours: 18:32
More

AnaptysBio Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Nektar Therapeutics Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
AbbVie, Inc. Upgrade
Esperion Therapeutics, Inc. Upgrade